ReviewFrontiers in cardiovascular medicine2026
Electroacupuncture regulates lipid metabolism through PPAR
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyperlipidemia is an independent risk factor for atherosclerotic cardiovascular disease, and a substantial proportion of patients remain inadequately controlled on statin therapy because single-target interventions cannot fully reverse the systemic inflammation and tissue injury driven by dysregulated lipid metabolism. Electroacupuncture (EA), a modern refinement of traditional acupuncture,has been reported to lower serum total cholesterol, triglycerides, and low-density lipoprotein cholesterol in clinical trials, yet the molecular basis of these effects has not been systematically synthesized. Here, we review the evidence that EA regulates lipid homeostasis through the peroxisome proliferator-activated receptor
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.